On this page

What is Myocarditis?
Recovery Time and Prognosis
Causes
Symptoms
When to Contact a Doctor
Diagnosis
Complications
Treatment
Prevention
Sources and Bibliography

What is Myocarditis?

The heart is a muscular pump approximately the size of an adult fist, divided into four chambers. Under normal conditions, it beats 60 to 100 times per minute, continuously circulating blood throughout the entire body.

Myocarditis is a disease characterized by inflammation of the heart muscle (myocardium).

How Common Is It?

While precise incidence data are limited, myocarditis is not particularly common. It affects tens of thousands of patients annually in the United States and proportional numbers globally. However, its importance is amplified by its potential severity: it is estimated that between 5 and 20% of all cases of sudden death in young adults are caused by myocarditis, making it a significant cause of unexpected cardiac mortality in otherwise healthy individuals.

Causes Overview

Myocarditis can affect people of any age and any health status. Its causes are numerous:

Viral infections (the most common cause)
Autoimmune diseases
Environmental toxins
Adverse drug reactions
Bacterial, fungal, or parasitic infections (less common)

Clinical Presentation

The majority of myocarditis cases are entirely asymptomatic and are only discovered incidentally through an electrocardiogram (ECG) or specific blood tests detecting cardiac injury markers. When the heart muscle becomes sufficiently inflamed, its pumping efficiency decreases, potentially causing:

Irregular heartbeat (arrhythmias)
Breathing difficulties
In extreme cases: formation of blood clots, heart attacks, or stroke

Recurrence

Myocarditis can recur. In some cases, repeated episodes can cause permanent cardiac structural changes. One example is dilated cardiomyopathy, a serious condition where the heart muscle weakens and the cardiac chambers enlarge. The risk of recurrence is estimated at approximately 10 to 15%, which is significant but not the most common outcome.

Recovery Time and Prognosis

The prognosis of myocarditis varies considerably depending on the underlying cause and disease severity:

Most cases (particularly those caused by viral infections) resolve spontaneously within a few weeks, often without the patient being aware of the condition.
Severe forms may require treatment over several months before resolution.
In this more severe category, recurrence is a recognized risk, and some patients develop persistent cardiac dysfunction.

Overall, complete recovery is the most common outcome in viral myocarditis, especially when the condition is recognized and managed promptly.

Causes

Myocarditis can affect anyone at any age. Possible causes are numerous, ranging from those responsible for mild, self-limited forms to those associated with life-threatening cardiac compromise. Myocarditis is not considered a hereditary disorder.

Viral Infections

Viruses are the most frequent cause of myocarditis in developed countries. Viral infections can affect virtually any part of the body, including the heart. Myocarditis may develop during a viral illness or, more commonly, in the days or weeks following a viral throat infection or similar respiratory or gastrointestinal illness.

The human immune system can fight off most viruses, such as the common cold, seasonal flu, or chickenpox. This ability also extends to cardiac involvement. Consequently, most cases of viral myocarditis resolve spontaneously within approximately one week without specific treatment.

Viruses most commonly associated with myocarditis include:

Adenoviruses and Coxsackie B viruses: The most frequently implicated
Influenza virus
Epstein-Barr virus (mononucleosis)
Rubella
Varicella-zoster virus (chickenpox)
Measles virus
Mumps virus
Echovirus
Parvovirus B19
Yellow fever virus
SARS-CoV-2 (COVID-19): Both direct viral infection of cardiac tissue and immune-mediated myocarditis have been described

An important pathophysiological mechanism is this: even after the initial viral infection has been cleared, cardiac inflammation can persist. This happens when the immune system mounts an exaggerated or self-sustaining response, continuing to attack cardiac tissue long after the virus is gone. This post-viral inflammatory mechanism may account for some of the most prolonged and severe forms of myocarditis.

Some cases of myocarditis have been observed as an adverse effect of the Pfizer-BioNTech COVID-19 vaccine (Comirnaty). This has also occurred, though less frequently, with the Moderna vaccine. The condition appears particularly in young males under 40 years of age, most commonly after the second dose.

Key points regarding vaccine-related myocarditis:

Cases are generally mild to moderate in severity and respond well to standard treatment.
The vast majority of cases resolve fully without lasting cardiac damage.
These events do not compromise the overall risk-benefit profile of COVID-19 vaccination. The profile remains overwhelmingly favorable, especially when you consider that SARS-CoV-2 infection itself carries a substantially higher risk of myocarditis than vaccination does.
Current guidelines in most countries continue to recommend COVID-19 vaccination across appropriate age groups

Other Causes

Less common but recognized causes of myocarditis include:

Infectious agents:

Fungal (mycotic) infections: Particularly in immunocompromised patients.
Parasites: Including Trypanosoma cruzi (which causes Chagas disease, a major cause of myocarditis in Latin America), Toxoplasma gondii, and others.
Bacteria: Including Borrelia burgdorferi (causing Lyme disease), Streptococcus (rheumatic fever), and Staphylococcus.

Toxic and pharmacological causes:

Alcohol: Chronic excessive alcohol use is a recognized cause of alcoholic cardiomyopathy and myocarditis
Illicit substances and recreational drugs: Cocaine, amphetamines, and others
Bites and stings: From spiders (particularly certain species like the black widow), wasps, and other venomous animals
Chemotherapy agents: Including anthracyclines, checkpoint inhibitors (immune-related adverse events), and targeted therapies
Radiotherapy: Radiation to the thorax can cause radiation-induced myocarditis

Autoimmune and systemic inflammatory diseases:

Systemic lupus erythematosus (SLE)
Rheumatoid arthritis
Sarcoidosis, particularly important because cardiac sarcoidosis carries a significant risk of arrhythmia and sudden death.
Giant cell myocarditis (a rare but highly aggressive autoimmune form)

Idiopathic Myocarditis

In a significant proportion of patients, the exact cause of myocarditis is never identified, even after thorough investigation. In many such cases, a viral etiology is suspected but cannot be confirmed. These cases are classified as idiopathic myocarditis and are managed based on clinical presentation and severity rather than an identified cause.

Symptoms

Often Asymptomatic

A critical and clinically important feature of myocarditis is that inflammation frequently causes no symptoms at all. Many patients recover completely without ever realizing they had cardiac involvement. In these cases, the condition is discovered incidentally or retrospectively.

Common Symptoms When Present

When symptoms do occur, they typically develop 7 to 14 days after a viral illness. The most common presenting symptom is:

Shortness of breath (dyspnea): This symptom often begins during physical activity but may worsen over time. It can lead to breathlessness even at rest or while sleeping, sometimes causing the patient to wake up. In such cases, sitting upright may help them breathe more easily.

Additional symptoms may include:

Fatigue and generalized weakness.
Palpitations and other cardiac rhythm disturbances (awareness of irregular, rapid, or forceful heartbeat).
Signs of the underlying infection:
- Fever.
- Muscle aches.
- Sore throat.
- Headache.
- Diarrhea.
Joint pain.
Reduced urinary output: A sign of reduced cardiac output affecting kidney perfusion.
Chest pain or pressure: May radiate to the shoulders and neck; can mimic the chest pain of a heart attack.
Leg swelling: From fluid retention secondary to reduced cardiac function (early heart failure).
Syncope (sudden loss of consciousness): Rare, but can occur due to severe cardiac arrhythmias.

Patients may experience all, none, or only some of these symptoms. The duration can vary, lasting from a few days to several weeks.

Myocarditis and Pericarditis: Frequent Co-occurrence

Myocarditis is frequently associated with pericarditis, which is an inflammation of the pericardium, the sac surrounding the heart. Many patients manifest symptoms of both conditions at the same time. This combined presentation, called myopericarditis, typically includes more prominent chest pain along with the cardiac symptoms of myocarditis.

Symptoms in Children

Myocarditis in children and infants often presents with more non-specific, vague symptoms that can make diagnosis particularly challenging:

General malaise and irritability
Poor appetite / feeding difficulties
Abdominal pain
Chronic cough
Fever
Respiratory difficulties
Rapid breathing (tachypnea)
Bluish discoloration of the skin (cyanosis): A serious sign indicating inadequate oxygenation, requiring immediate medical attention

When to Contact a Doctor

Consult a physician promptly if you experience any of the symptoms listed above associated with myocarditis, particularly chest pain and shortness of breath. Do not dismiss respiratory or cardiac symptoms that appear in the context of or following a viral illness.

Seek emergency care (call emergency services or go to the nearest emergency department) immediately if you experience:

Sudden, severe chest pain

Difficulty breathing at rest

Fainting or loss of consciousness

Signs of heart failure (rapidly worsening breathlessness, inability to lie flat)

Diagnosis

Myocarditis can be difficult to diagnose because its symptoms overlap substantially with many other cardiac and non-cardiac conditions. The diagnostic workup typically involves a combination of:

Blood Tests

Cardiac biomarkers: Troponin I or T and creatine kinase-MB (CK-MB). Elevated levels indicate myocardial (heart muscle) injury.
Inflammatory markers: C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are non-specific but support the diagnosis of inflammation.
Complete blood count: May show leukocytosis (elevated white blood cells) if infection is present.
Viral serology: To identify specific viral causes when clinically suspected.
Autoantibody testing: For autoimmune causes.

Chest X-Ray

A chest X-ray may show:

Cardiomegaly (enlarged heart) in cases with significant cardiac dysfunction
Pulmonary congestion suggesting early cardiac failure

Electrocardiogram (ECG)

An ECG may reveal:

ST-segment changes: Can mimic those seen in a heart attack
Arrhythmias: Including premature beats, bundle branch blocks, or more serious rhythm disturbances
T-wave abnormalities: Reflecting myocardial inflammation or damage

Echocardiogram

An echocardiogram (cardiac ultrasound) assesses:

Ventricular function: Reduced ejection fraction indicates impaired pumping ability
Wall motion abnormalities: Localized or diffuse areas of abnormal heart muscle movement
Pericardial effusion: If pericarditis is also present
Ventricular dilation: Suggesting progression toward dilated cardiomyopathy

Cardiac MRI

Cardiac magnetic resonance imaging (CMR) has become a key non-invasive diagnostic tool for myocarditis. Using tissue characterization techniques (T1 mapping, T2 mapping, late gadolinium enhancement), CMR can:

Detect myocardial edema (tissue swelling from inflammation).
Identify areas of myocardial fibrosis or necrosis.
Characterize the extent and pattern of inflammation, which helps distinguish myocarditis from other causes.

Endomyocardial Biopsy

Endomyocardial biopsy (EMB), where a tiny sample of heart muscle tissue is extracted via catheter for microscopic pathological analysis, remains the histological gold standard for diagnosing myocarditis. However, given its invasive nature and sampling limitations, it is reserved for:

Severe or rapidly deteriorating myocarditis unresponsive to treatment
Suspected specific forms (giant cell myocarditis, eosinophilic myocarditis, cardiac sarcoidosis)
Cases where a definitive tissue diagnosis would significantly change management

Complications

The vast majority of viral myocarditis cases resolve without complications. However, in some patients the inflammation is more serious, placing them at risk of significant or permanent cardiac damage.

Heart Failure

The most important long-term complication is heart failure, which is the heart’s inability to pump sufficient blood to meet the body’s needs. Severe or recurrent myocarditis may progress to:

Dilated cardiomyopathy: The most feared long-term sequela; requires chronic medical management and, in refractory cases, cardiac transplantation

Thromboembolism: Heart Attack and Stroke

If the heart muscle is damaged and cannot pump effectively, blood can stagnate and form clots within the cardiac chambers. These clots can:

Block the coronary arteries, causing myocardial infarction (heart attack)
Travel to the cerebral vasculature, causing stroke (ischemic)

Arrhythmias

Myocarditis can disrupt the heart’s electrical conduction system, leading to cardiac arrhythmias. These may include dangerous conditions like ventricular tachycardia or fibrillation, which can result in sudden cardiac death. This mechanism explains why myocarditis is a recognized cause of sudden death in young athletes.

Sudden Cardiac Death

Rarely, myocarditis becomes so severe that it leads to fatal outcomes. This can happen either acutely, due to arrhythmia, or gradually, as a result of progressive cardiac failure that does not respond to treatment. This is the mechanism underlying some cases of sudden unexpected death in previously healthy young individuals.

Treatment

Treatment of myocarditis depends on underlying cause and disease severity.

Rest: The Cornerstone of Initial Management

Complete rest is strongly recommended from the moment of diagnosis. Patients are typically advised to abstain from all physical exercise and competitive sport for several months, to minimize cardiac stress and allow the inflamed myocardium to heal. Premature return to physical activity is a recognized trigger for clinical deterioration and arrhythmia.

International cardiology societies (including the European Society of Cardiology and the American Heart Association) generally recommend:

No competitive sports or high-intensity exercise for a minimum of 3 to 6 months following myocarditis diagnosis
Return to activity only after normalization of cardiac biomarkers, ECG, echocardiogram, and cardiac MRI findings

Symptomatic Relief

Analgesics and NSAIDs: For chest pain relief and fever reduction; NSAIDs (such as ibuprofen) are commonly used in mild-to-moderate myocarditis, though their use in severe myocarditis with significant ventricular dysfunction requires caution
Colchicine: Increasingly used alongside NSAIDs, particularly when pericarditis is also present (myopericarditis)

Treatment of the Underlying Cause

Viral myocarditis: No specific antiviral treatment exists for most viral causes; the approach is supportive, allowing the body’s immune system to clear the infection. The exception is herpesvirus-related myocarditis (e.g., CMV, HSV), for which antiviral therapy (acyclovir, ganciclovir) may be beneficial.
Bacterial myocarditis: Antibiotics are prescribed targeting the specific organism identified.
Corticosteroids: Used selectively and cautiously, particularly in autoimmune forms such as giant cell myocarditis, eosinophilic myocarditis, cardiac sarcoidosis, and lupus, as well as in immune-checkpoint inhibitor-related myocarditis. Routine use in viral myocarditis is generally avoided, as it may impair viral clearance.
Immunosuppressive therapy: For autoimmune forms not responding to corticosteroids alone

Management of Severe Myocarditis: Hospital-Based Care

Patients with significant hemodynamic compromise, life-threatening arrhythmias, or acute heart failure require hospitalization and intensive monitoring. Hospital-based treatments may include:

ACE inhibitors and ARBs (angiotensin receptor blockers / sartans): Reduce blood pressure and cardiac afterload, improving ventricular function and protecting the myocardium
Beta-blockers: Regulate heart rate, control arrhythmias, and reduce cardiac oxygen demand.
Diuretics: Manage fluid overload and reduce pulmonary congestion.
Intravenous inotropes: For acute cardiogenic shock, these medications temporarily enhance cardiac contractility.
Mechanical circulatory support: Intra-aortic balloon pump, ventricular assist devices (VADs), or extracorporeal membrane oxygenation (ECMO) for the most critically ill patients as a bridge to recovery or transplantation.
Antiarrhythmic medications or implantable cardioverter-defibrillator (ICD): For significant rhythm disturbances.

Lifestyle Recommendations

For all patients diagnosed with myocarditis:

Complete physical rest: Until specifically cleared by a cardiologist
Avoid all activities that stress the heart: Including competitive and recreational sports, heavy lifting, and high-intensity exercise
Follow a low-sodium diet: To reduce fluid retention and cardiac workload
Avoid alcohol: Alcohol is directly cardiotoxic and can worsen myocardial inflammation and function
Avoid smoking: Smoking impairs cardiovascular recovery and increases arrhythmia risk

Prevention

Unfortunately, there are no specific measures known to prevent myocarditis. Since most cases stem from viral infections, general hygienic practices that reduce infection risk represent the most practical preventive strategies. These include frequent handwashing, avoiding close contact with ill individuals, and staying up to date with recommended vaccinations. Vaccinations help prevent infections that can cause myocarditis, such as measles, mumps, rubella, and influenza.

There is currently no known way to prevent recurrence of myocarditis once it has occurred, though the recurrence risk is relatively low (estimated at 10–15%). Long-term cardiac follow-up after myocarditis is recommended to detect any delayed development of cardiomyopathy.

Myocarditis: Symptoms, Causes, and Treatment